MENU
LPCN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lipocine (LPCN) Ownership - Who owns Lipocine?

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology... Show more

Profile

Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
17
Web
https://www.lipocine.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
17.6M
P/E Ratio
N/A
Total Cash
19.72M
Projected Growth
N/A
Total Debt
1.48M
Revenue
3.67M
Risk (Beta)
1.32
Dividend Yield
N/A
Total Cash/Share
3.69
Total Debt/Equity
N/A
Revenue/Share
0.68 USD as % of share price

Fundamentals

LPCN
Capitalization
17.6M
P/E Ratio
N/A
Risk (Beta)
1.32
Dividend Yield
N/A
Total Cash
19.7M
Total Cash/Share
3.69
Total Debt
1.48M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.68%
Revenue
3.68M
ROE
N/A
Book Value
19.2M
P/B Ratio
0.92
Cash Flow
N/A
Earnings
-1.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.86K
Current Ratio
15.64
Current Revenue Per Employee
5866.50
Dividends Per Share - Security
N/A
EBITDA
-6.42M
Float
N/A
Float - Current
N/A
Gross Income Margin
-479.60
Revenue To Assets
-23.38
Shares Held By Institutions
2.73M
Shares Outstanding - Current
5.35M
Total Liabilities
1.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-33.402
View a ticker or compare two or three
LPCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
17
Web
https://www.lipocine.com